Mitiperstat (AZD4831) is an effective oral inhibitor of myeloperoxidase (MPO). Mitiperstat inhibits MPO and thyroid peroxidase (TPO) with IC50s of 1.5 nM and 0.69 µM. Mitiperstat exhibits a weak inhibitory activity against CYP3A4 with an IC50 of 6 µM. Mitiperstat can reduce inflammation and improve microvascular function, and it can be used in studies related to heart failure, preserved or mildly reduced ejection fraction, non-alcoholic fatty liver disease, and chronic obstructive pulmonary disease[1][2][3][4].
Molekulargewicht:
334.82
Reinheit:
99.12
CAS Nummer:
[1933460-19-5]
Formel:
C15H15ClN4OS
Target-Kategorie:
Cytochrome P450,Glutathione Peroxidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten